1. Association between hyperphosphatemia (serum phosphorus ≥4
Association between hyperphosphatemia (serum phosphorus ≥4.3 mg/dl) and the composite outcome (death or progression to ESRD) in different CKD-NDD subgroups.
Association between hyperphosphatemia (serum phosphorus ≥4.3 mg/dl) and the composite outcome (death or progression to ESRD) in different CKD-NDD subgroups. Here are depicted the HR associated with hyperphosphatemia compared with the reference group (serum phosphorus ≥3.3 but <3.8 mg/dl) in different stages of CKD, age category, sex, and diabetes status. All results are adjusted for the case mix and hemoglobin, total calcium, uric acid, ACE inhibitors, vitamin D, and calcium salts use.
Antonio Bellasi et al. CJASN 2011;6:
©2011 by American Society of Nephrology